VIA
ASMB icon

Virtus Investment Advisers’s Assembly Biosciences ASMB Stock Holding History

Virtus Investment Advisers’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$392K Buy
14,251
+6,698
+89% +$182K 0.09% 287
2026
Q1 		$210K Buy
7,553
+184
+2% +$5.25K 0.06% 336
2025
Q4 		$251K Buy
+7,369
New +$237K 0.07% 331

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Virtus Investment Advisers's ASMB Position: Q2 2026 in Review

Virtus Investment Advisers increased its Assembly Biosciences (ASMB) stake by 89% in Q2 2026, buying an estimated $182K and bringing the position to 14,251 shares worth $392K. The position accounts for 0.09% of the portfolio, ranked #287.

Virtus Investment Advisers first reported a position in ASMB in Q4 2025 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Virtus Investment Advisers held 14,251 shares of Assembly Biosciences worth $392K as of Q2 2026.
  • Virtus Investment Advisers bought 6,698 Assembly Biosciences shares in Q2 2026, an estimated $182K.
  • Assembly Biosciences made up 0.09% of Virtus Investment Advisers's portfolio in Q2 2026, its #287 holding.
  • Virtus Investment Advisers first reported a position in Assembly Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.